Cambridge Bioscience is delighted to announce a strategic distribution partnership with Bangs Laboratories Cambridge Bioscience following our recent acquisition of Stratech Scientific, expanding access to the company’s innovative microsphere, nanoparticle and magnetic particle technologies for life science, diagnostic and research organisations across the UK and Ireland.
The partnership will provide scientists with streamlined access to Bangs Laboratories’ extensive portfolio of products, including microspheres, magnetic particles and magnetic microspheres, gold nanoparticles, particle conjugation kits, magnetic particle-based products and isolation kits, flow cytometry reagents, bead buffers and solutions, dyes and stains, surfactants, magnetic separators and magnetic particle mixers.
Bangs Laboratories is a US-based company that provides ISO 13485:2016-certified solutions for diagnostic companies, instrument manufacturers and life science researchers. The company specialises in microsphere synthesis, nanoparticle technology and fine particle analysis, and is widely recognised for its expertise in microsphere-based reagents and analytical instrument calibrators that support advanced diagnostics and life science applications.
Through this partnership, Cambridge Bioscience will provide local technical support, product expertise and customer service, ensuring researchers and developers across the UK and Ireland can fully leverage Bangs Laboratories’ trusted technologies to accelerate scientific discovery and support the development of next-generation diagnostic solutions.
The collaboration also brings increased visibility to Bangs Laboratories’ innovative Magnefy™ range and further strengthens Cambridge Bioscience’s commitment to providing the UK and Ireland life science community with high-quality research tools and technologies that enable innovation, discovery and translational research.
Learn more about the Bangs Laboratories portfolio or contact our Bangs Laboratories specialists.